Ultratech India

Ultratech India is a pharmaceutical company headquartered in Mumbai, India, specializing in the manufacture and export of Active Pharmaceutical Ingredients (APIs), pharmaceutical pellets, and finished dosage forms. Established in 1992, the company operates WHO-GMP certified facilities and has built a significant presence in the global generic market, exporting to over 40 countries. Their therapeutic focus is broad, encompassing oncology, cardiology, gastroenterology, and anti-diabetics. Ultratech India is particularly recognized for its expertise in pelletization technology and the production of high-quality oncology generics. The company also functions as a contract development and manufacturing organization (CDMO), providing integrated solutions from process development to commercial-scale production. With a commitment to international quality standards, they serve as a key supplier for both domestic and international pharmaceutical markets.